Neostigmine (Juno) TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: neostigmine
Brand name
(ARTG)
: NEOSTIGMINE JUNO neostigmine methylsulfate 2.5 mg/1 mL solution for injection ampouleDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Neostigmine is indicated for:, Reversal of the effects of non-depolarising neuromuscular blocking agents., Prophylaxis and treatment of post-operative intestinal atony and urinary retention., Treatment of myasthenia gravis during acute exacerbations, when the condition is severe or in neonates.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Intramuscular
- Clear, colourless solution
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 10 ampoules pack
- 50 ampoules pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient neostigmine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems